secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2023-11-08T23:59:59+00:00
Accession:  0001493152-23-039836
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

AIM Immunotech presents ovarian cancer chemoimmunotherapy data at SITC 2023
---------------------------------------------------------------------------

- Poster presented at SITC 38th Annual Meeting (Nov 1-5, 2023) by UPMC collaborators.
- Data on combination intraperitoneal chemoimmunotherapy for recurrent platinum-sensitive ovarian cancer.
- Study demonstrates T-cell chemotactic locoregional response per poster title.
- Poster available on company's investor website.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315223039836/0001493152-23-039836-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315223039836/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-039836

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer